文献速递神经肿瘤小儿神经外科与脑积水

儿童视路胶质瘤治疗后的极长期结局:一项纵向队列研究

Very long-term outcomes of pediatric patients treated for optic pathway gliomas: A longitudinal cohort study.
PubMed 文献 · Neuro Oncol · 2024-01-01

研究纳入1980年1月至2015年12月在Gustave Roussy(GR)治疗、诊断时未满18岁且诊断后存活5年的视路胶质瘤(OPG)患者182例,中位随访17.2年(范围5-41年)。5年后发生82例复发、9例第二恶性肿瘤和15例死亡,20年条件总生存率为79.9%(95%CI=71-86),无晚期事件生存率为43.5%(95%CI=36-51);NF1患者放疗暴露(HR=6,95%CI=1.7-21.2)和下丘脑受累(HR=3.2,95%CI=1.4-7.3)与条件总生存率显著相关。

要点

  • 5年OPG幸存者中95%存在任一健康问题,常见视力<1/10(n=109)、垂体功能减退(n=106)和神经认知障碍(n=89)。
  • NF1患者放疗暴露(HR=6,95%CI=1.7-21.2)与下丘脑受累(HR=3.2,95%CI=1.4-7.3)与条件总生存率显著相关。
  • 中位诊断后4.2年,21例患者共观察到33次脑血管事件。

核心结论

  • 晚期复发、第二恶性肿瘤和脑血管疾病是导致过早死亡的严重晚期事件;发病率高,需要癌症后照护以改善生活质量;风险因素可考虑用于更好地分层长期随访。

研究设计与样本

  • 研究为纵向队列研究,纳入1980年1月至2015年12月在Gustave Roussy(GR)治疗、诊断时未满18岁且诊断后存活5年的OPG患者,共182例5年OPG儿童幸存者(男女比0.8,35%为1型神经纤维瘤病[NF1])。
  • 死亡与身体健康状况数据来自病历资料,并通过GR长期随访项目和法国国家死亡登记库对纳入法国儿童癌症幸存者研究(French Childhood Cancer Survivor Study)的患者进行更新。

主要发现

  • 中位随访17.2年(范围5-41年),5年后作为首次事件登记82例复发、9例第二恶性肿瘤和15例死亡。
  • 20年条件总生存率(C-OS)为79.9%(95%CI=71-86),无晚期事件生存率为43.5%(95%CI=36-51)。
  • 多变量分析中,NF1患者放疗暴露(HR=6,95%CI=1.7-21.2)和下丘脑受累(HR=3.2,95%CI=1.4-7.3)与C-OS显著相关。
  • 95%的5年OPG幸存者存在任一健康问题,包括视力<1/10(n=109)、垂体功能减退(n=106)和神经认知障碍(n=89)。
  • NF1(HR 2.1)与性早熟相关;中位诊断后4.2年,21例患者共观察到33次脑血管事件。

临床怎么用

  • 作者认为风险因素可考虑用于更好地分层长期随访,并指出发病率高、需要癌症后照护以改善生活质量。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Optic pathway gliomas (OPGs) represent 5% of childhood brain tumors. Successive relapses lead to multiple treatments exposing to late complications. METHODS: We included patients treated at Gustave Roussy (GR) between January 1980 and December 2015 for OPG, before 18 years old and alive at 5 years from diagnosis. Mortality and physical health conditions data were extracted from medical data files and updated, thanks to the GR long-term follow-up program and French national mortality registry for patients included in the French Childhood Cancer Survivor Study. RESULTS: We included 182 5-year OPG-childhood survivors in the analysis (sex ratio M/F 0.8, 35% with neurofibromatosis type 1 [NF1]). With a median follow-up of 17.2 years (range = 5-41), we registered 82 relapses, 9 second malignancies, and 15 deaths as first events after 5 years, resulting in 20-year conditional overall survival (C-OS) and late events-free survival of 79.9% (95% confidence interval [CI] = 71-86) and 43.5% (95% CI = 36-51), respectively. Radiotherapy exposure in NF1 patients (hazard ratio [HR] = 6, 95% CI = 1.7-21.2) and hypothalamic involvement (HR = 3.2, 95% CI = 1.4-7.3) were significantly associated with C-OS in multivariable analyses. Ninety-five percent of 5-year OPG survivors suffered from any health condition, especially visual acuity "<1/10" (n = 109), pituitary deficiency (n = 106), and neurocognitive impairment (n = 89). NF1 (HR 2.1) was associated with precocious puberty. With a median time post-diagnosis of 4.2 years, 33 cerebrovascular events were observed in 21 patients. CONCLUSIONS: Late relapses, second malignancies, and cerebrovascular diseases are severe late events resulting in premature mortality. Morbidity is high and needs after-cancer care to improve quality of life. Risk factors could be considered to better stratify long-term follow-up.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Morin A, Allodji R, Kariyawasam D, et al. Very long-term outcomes of pediatric patients treated for optic pathway gliomas: A longitudinal cohort study. Neuro Oncol. 2024. PMID: 38465768. doi:10.1093/neuonc/noae045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。